Adolescents and young adults in the U.S. are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with ...

Use of GLP-1 weight-loss drugs in the U.S. has tripled since 2024.

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. That's about 40 million people—as ...

The drug has shown itself to be effective for weight loss — but its high price is making it a hard sell for many would-be ...

SAN DIEGO, Nov. 1, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and ...

Poison centers in the US are receiving more GLP-1 RA exposure reports following FDA approval for GLP-1 RA use in weight loss.

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

GLP-1 drugs such as Ozempic and Mounjaro are a revolution, not a trend. These weight loss drugs are one of the hottest markets in healthcare, and there’s been a dramatic surge in the number of ...

A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss. A record high 11% of Americans are taking a GLP-1 medication for weight loss, according to Gallup, up 3% ...